Study tracks lifesaving drug use in C-Section bleeding emergencies
NCT ID NCT07278037
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks back at medical records of 648 women who had heavy bleeding after a C-section. Researchers want to see how often the drug tranexamic acid (TXA) was given over the years, and whether more use led to better outcomes like less blood loss or fewer transfusions. The goal is to understand real-world use of a treatment that can cut death from bleeding by 31%.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- tranexamic acid (TXA)
- What this could lead to
- If successful, this study could confirm that wider use of TXA after C-section bleeding improves survival and reduces complications.
- What could go wrong
- This is a retrospective chart review, not a controlled trial, so it can't prove cause and effect. Results may not apply to all hospitals or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Siriraj Hospital
RECRUITINGBangkoknoi, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could having a partner present during emergency C-Sections improve Mothers' mental health?
- When pain strikes during C-Section: what Women's stories reveal
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can we improve emergency C-Sections for the sickest mothers?
- Medical glue vs. internal bleeding: a new hope?
- Which drug stops Post-Birth bleeding better? a Head-to-Head test